Soros Fund Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,000,000
| Closed | -$1.18M | – | 220 |
|
|
2025
Q1 | $1.18M | Sell |
1,000,000
-1,372,265
| -58% | -$1.62M | 0.02% | 178 |
|
|
2024
Q4 | $4.34M | Buy |
2,372,265
+274,265
| +13% | +$502K | 0.07% | 147 |
|
|
2024
Q3 | $3.57M | Buy |
2,098,000
+400,000
| +24% | +$680K | 0.05% | 133 |
|
|
2024
Q2 | $2.33M | Buy |
1,698,000
+65,000
| +4% | +$89.1K | 0.04% | 143 |
|
|
2024
Q1 | $6.12M | Buy |
+1,633,000
| New | +$6.12M | 0.1% | 108 |
|
|
2019
Q1 | – | Sell |
-135,000
| Closed | -$999K | – | 179 |
|
|
2018
Q4 | $999K | Buy |
+135,000
| New | +$999K | 0.03% | 150 |
|
|
2017
Q4 | – | Sell |
-670,400
| Closed | -$3.52M | – | 244 |
|
|
2017
Q3 | $3.52M | Buy |
+670,400
| New | +$3.52M | 0.08% | 105 |
|